Fosun Pharmaceutical Deeply Embraces AI, Self-developed PharmAID Decision Intelligence Platform Boosts Efficient Innovation

---
Fosun Pharmaceutical Deeply Embraces AI, Self-developed PharmAID Decision Intelligence Platform Boosts Efficient Innovation
Vote:
0 0
Previous Per Franzén appointed new CEO of EQT AB as of May 2025
Next Boldyn Networks appoints Sara Dickinson as Group CFO

Related News

Fosun Pharma Participates in BEYOND Expo 2023 to Showcase Its Innovative R&D Achievements

Fosun Pharma Develops Innovative Artemisinin-based Antimalarial Drugs Contributing to the Efforts for A Malaria-free World Through the Belt and Road Initiative

Fosun Pharma Announces its 15th Corporate Social Responsibility Report: Continuous Innovation for the Benefit of the Public

IFF Pharma Solutions Wins Pharmaceutical Technology Excellence Award

Fosun Pharma and Henlius Entered into an Exclusive License Agreement for Serplulimab in the US

Nippon Express (UK) Receives IATA CEIV Pharma Certification for Its Facility in Heathrow Airport Suburb

menu
menu